Drug-price reforms need not affect research on rare diseases – or the Canadians who have them

On Aug. 9, the Patented Medicine Prices Review Board of Canada announced new drug-pricing regulations for new patented medicines that […]

Read More
Tags: , , , , , , , , , , , , , , , Comments Off on Drug-price reforms need not affect research on rare diseases – or the Canadians who have them